TDM Journal Club: Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis Immunization during Pregnancy

Therapeutic Drug Monitoring

Volumn 37, Issue 3, 2014, Pages 283-284

  Leibson, Tom ^a   St Onge, Maude ^b   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL PRACTICE; DIPHTHERIA; DRUG SAFETY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; MIDDLE AGED; NOTE; PERTUSSIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; TETANUS; UNSPECIFIED SIDE EFFECT; IMMUNOLOGY; NEWBORN; WHOOPING COUGH;

DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; WHOOPING COUGH;

EID: 84929944306     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000143     Document Type: Note

References (5)

1. Centers for Disease Control and Prevention. 2012 final pertussis surveillance report. 1.
2. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced di phtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62:131-135.
3. Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants. JAMA. 2014; 331:1760-1769.
4. Jimenez-Truqye N, Edwards K M. Maternal pertussis immunization: can it help infants? JAMA. 2014;311:1736-1737.
5. Arnold DM, Burns KE, Adhikari NK, et al. The design and interpretation of pilot trials in clinical research in critical care. Crit Care Med. 2009;37(suppl 1):S69-S74.